Session information

Oral Presentation

(A) Pharmaceutical Chemistry

[31-502-am] Structure-activity relationship

Sun. Mar 31, 2024 8:30 AM - 9:30 AM [Room 502] Conference Center 502 (5F)

Chair: Fumika Yakushiji, Hiroki Kakuta

+Add all to schedule

8:30 AM - 8:42 AM

[31-502-am01S] Structure-activity relationship study of purine derivatives with protein kinase CK2 inhibitory activity
—Introduction of various aliphatic groups to the 2-position on the purine ring—

○Shiori Nakatani¹, Eri Nakagawa¹, Kenji Yoshioka¹, Keiji Nishiwaki¹, Shinya Nakamura¹, Masato Tsuyuguchi^2,3, Takayoshi Kinoshita², Isao Nakanishi¹ (1. Fac. Pharm., Kindai Univ., 2. Grad. Sch. Sci., Osaka Met. Univ., 3. KEK)

8:42 AM - 8:54 AM

[31-502-am02S] Development of a Novel Salt-Inducible Kinase Activator

○Kenshiro Nakamura^1,2, Tomoya Sugai^1,2, Kei Nishida^2,3, Yukiko Ishikawa², Takeshi Kanda^2,4, Masashi Yanagisawa^2,3, Noriki Kutsumura^1,2,3 (1. College of Chem., Univ. Tsukuba, 2. IIIS, Univ. Tsukuba, 3. Ph.D. Program in Humanics, Univ. Tsukuba, 4. Dept. Neurophysiology, Nara Medical Univ.)

8:54 AM - 9:06 AM

[31-502-am03S] Design and synthesis of 2,4,5-trisubstituted pyrimidine-centred salt-inducible kinase inhibitor

○Ruburika Nagao^1,2, Tomoya Sugai^1,2, Kei Nishida^2,3, Yukiko Ishikawa², Takeshi Kanda^2,4, Masashi Yanagisawa^2,3, Noriki Kutsumura^1,2,3 (1. Degree Program in Pure and Appl. Sci., Univ. Tsukuba, 2. IIIS, Univ. Tsukuba, 3. Ph.D. Program in Humanics, Univ. Tsukuba, 4. Dept. Neurophysiology, Nara Medical Univ.)

9:06 AM - 9:18 AM

[31-502-am04S] Structure-Activity Relationship Studies of Oxysterol Derivatives Modulating STING Pathway Activation

○Elena Nakasato¹, Kanoko Takahashi², Rio Tsuyuki³, Yoshihiko Kuchitsu², Minoru Ishikawa², Kojiro Mukai², Tomohiko Taguchi², Kenji Ohgane^1,3 (1. Grad. Sch. Sci., Ochanomizu Univ., 2. Grad.Sch.Life.Sci., Tohoku Univ., 3. Sci., Ochanomizu Univ.)

9:18 AM - 9:30 AM

[31-502-am05] Investigation of the antimicrobial activity and cytotoxicity of myticalin A6 (3-23)-Trp-Pro-Arg-OH derivatives substituted with Trp at position 6 or 9

○Keiko Okimura¹, Tatsuo Takahashi¹, Kana Kamiya¹, Miho Kajino¹, Tohru Daikoku¹ (1. Fac. Pharm. Sci., Hokuriku Univ.)

Authentication

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Please log in with your participant account.
» Participant Log In

▲